Therapeutics for Equine Protozoal Myeloencephalitis
Veterinary Clinics of North America: Equine Practice, ISSN: 0749-0739, Vol: 33, Issue: 1, Page: 87-97
2017
- 8Citations
- 8Usage
- 79Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations8
- Citation Indexes8
- CrossRef7
- Usage8
- Abstract Views8
- Captures79
- Readers79
- 79
Review Description
Equine protozoal myeloencephalitis is an infectious disease of the central nervous system caused by Sarcocystis neurona or Neospora hughesi. Affected horses routinely present with progressive and asymmetrical neurologic deficits. The diagnosis relies on the presence of neurologic signs, ruling out other neurologic disorders, and the detection of intrathecally derived antibodies to either S neurona and/or N hughesi. Recommended treatment is use of an FDA-approved anticoccidial drug formulation. Medical and supportive treatment is provided based on the severity of neurologic deficits and complications. This article focuses on recent data related to diagnosis, pharmacologic treatment, and prevention.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0749073916300840; http://dx.doi.org/10.1016/j.cveq.2016.12.001; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85011024558&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/28161037; https://linkinghub.elsevier.com/retrieve/pii/S0749073916300840; https://uknowledge.uky.edu/gluck_facpub/66; https://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1065&context=gluck_facpub; https://dx.doi.org/10.1016/j.cveq.2016.12.001
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know